Since studies in mouse suggest that this drug may accelerate the development of skin tumor by sunlight. It is recommended to avoid exposure to sunlight during medication of this drug. Patients being exposed to sun should avoid using this drug yesterday, today, and tomorrow.
During early therapy, apply after using limited area of skin.
To avoid bacterial resistance, notify sensitivity and medicate minimum period required.
Make an observation sufficiently, since sensitization may occur. If sensitized symptoms (itching, redness, swelling, papula, phlyctenule etc) develop, discontinue the application.
Bacterial resistance to antibiotics may occur in case of using for a long term. Discontinue application and take proper treatment.